JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB79540

Anti-Tau (phospho S198) antibody [EPR2400]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Recombinant
  • What is this?

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Recombinant Monoclonal TAU phospho S198 antibody. Suitable for IHC-P, IP, WB and reacts with Mouse, Rat, Human samples. Cited in 7 publications.

View Alternative Names

MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau, MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau

7 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast cancer tissue sections labeling Tau with purified ab79540 at 1 : 1000 (0.423 μg/ml). Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 2 (pH 9.0). Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used. PBS instead of the primary antibody was used as the negative control. Postive staining on human breast cancer without alkaline phosphatase treatment (image A). No staining on human breast cancer with alkaline phosphatase treatment (image B). The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunoprecipitation - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)
  • IP

Lab

Immunoprecipitation - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)

Purified ab79540 at 1/50 dilution (2μg) immunoprecipitating Tau in SH-SY5Y whole cell lysate.
Lane 1 (input) : SY-SY5Y (Human neuroblastoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab79540 + SH-SY5Y whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab79540 in SH-SY5Y whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 50-70 kDa

All lanes:

Immunoprecipitation - Anti-Tau (phospho S198) antibody [EPR2400] (ab79540)

Predicted band size: 78 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat cerebrum tissue sections labeling Tau with purified ab79540 at 1 : 1000 (0.423 μg/ml). Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 2 (pH 9.0). Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used. PBS instead of the primary antibody was used as the negative control. Postive staining on rat cerebrum without alkaline phosphatase treatment (image A). No staining on rat cerebrum with alkaline phosphatase treatment (image B). The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse cerebrum tissue sections labeling Tau with purified ab79540 at 1 : 1000 (0.423 μg/ml). Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 2 (pH 9.0). Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used. PBS instead of the primary antibody was used as the negative control. Postive staining on mouse cerebrum without alkaline phosphatase treatment (image A). No staining on mouse cerebrum with alkaline phosphatase treatment (image B). The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)
  • WB

Supplier Data

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)

All lanes:

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (ab79540) at 1/1000 dilution

Lane 1:

Untreated SH-SY5Y (Human neuroblastoma epithelial cell) whole cell lysate at 15 µg

Lane 2:

SH-SY5Y treated with 1µM okadaic acid and 200nM calyculin a for 60 minutes, whole cell lysate at 15 µg

Lane 3:

SH-SY5Y treated with 1µM okadaic acid and 200nM calyculin a for 60 minutes whole cell lysate, then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 78 kDa

Observed band size: 50-70 kDa

false

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)
  • WB

Supplier Data

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)

All lanes:

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (ab79540) at 1/10000 dilution

Lane 1:

Mouse hippocampus lysate at 15 µg

Lane 2:

Mouse hippocampus lysate, the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg

Lane 3:

Rat hippocampus lysate at 15 µg

Lane 4:

Rat hippocampus lysate, the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 78 kDa

Observed band size: 50-70 kDa

false

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)
  • WB

CiteAb

Western blot - Anti-Tau (phospho S198) antibody [EPR2400] (AB79540)

Western Blotting using Anti-Tau (phospho S198) antibody [EPR2400], ab79540. Publication image from Ercan, E. et al., 2017, Mol Neurodegener, 29157277. Legend direct from paper.

A number of antibodies failed to detect tau in hTg-Tau brain lysates. a Immunoblotting with recombinant tau (full length (1–441), truncated (1–421) and caspase 3 cleaved ((1–441) + Casp3) shows that all tau forms can be detected with a pan-tau antibody (Dako, left), whereas the C3-D421 antibody only detects the truncated and the caspase 3 cleaved form of tau (right). b and c Tau isoform-specific antibodies failed to detect tau in hTg-Tau brain lysates as well as the recombinant protein in the tau ladder. d, e, f and g No signal was detected by the meK311, pT212, pS238 and C3-D421 antibodies in hTg-Tau mouse brains, possibly due to the low abundance of these modifications. h Actin demonstrates equal loading for all samples. Tg : hTg-Tau mouse, KO : Tau-KO mouse brain lysate, TL : recombinant tau ladder

false

  • Carrier free

    Anti-Tau (phospho S198) antibody [EPR2400] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2400

Isotype

IgG

Carrier free

No

Reacts with

Human, Rat, Mouse

Applications

IHC-P, WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The specificity of this antibody refers to P10636-8.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p><strong>For unpurified use at 1/100 - 1/250.</strong></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/50000 - 1/100000.</strong></p>" }, "Mouse": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p><strong>For unpurified use at 1/100 - 1/250.</strong></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/50000 - 1/100000.</strong></p>" }, "Rat": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p><strong>For unpurified use at 1/100 - 1/250.</strong></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/50000 - 1/100000.</strong></p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tau also known as microtubule-associated protein Tau (MAPT) plays an important role in stabilizing microtubules in neuronal cells. Tau is primarily found in the central nervous system but also exists in peripheral neurons. Human Tau protein comes in six isoforms due to alternative splicing with molecular weights ranging from 48 kDa to 67 kDa. This protein predominantly locates in the axons of neurons where it maintains the stability of microtubule tracks necessary for axonal transport.
Biological function summary

Tau is involved in the assembly and stabilization of microtubules essential for maintaining neuronal structure. It interacts with microtubule-binding domains (MBD) to bind and bundle microtubules facilitating intracellular transport. Tau forms a part of the neuronal cytoskeleton complex working closely with other cytoskeletal proteins to preserve the proper axonal transport and function. Abnormally phosphorylated Tau often termed phospho-Tau disrupts this complex affecting microtubule stability.

Pathways

Tau has critical involvement in several signaling cascades such as the microtubule-binding and transport pathways. Glycogen synthase kinase 3 beta (GSK3β) and cyclin-dependent kinase 5 (CDK5) frequently phosphorylate Tau controlling its interaction with microtubules. Phosphorylated Tau accumulates leading to the formation of neurofibrillary tangles often observed in neurodegenerative conditions. Additionally Tau interacts with GAPDH impacting cellular energy regulation through potential pathway cross-talk involving oxidative stress responses.

Tau is closely associated with Alzheimer's disease and frontotemporal dementia. In Alzheimer's disease hyperphosphorylated Tau aggregates into paired helical filaments forming neurofibrillary tangles while similar aggregates are observed in frontotemporal dementia. In these conditions Tau links to amyloid precursor protein (APP) where misregulated phosphorylation-driven interactions contribute to neurodegeneration. Identifying phospho-Tau and its altered interactions with related proteins aids in understanding and potentially treating these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
See full target information MAPT phospho S198

Additional targets

MAPT phospho S198

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Cellular and molecular neurobiology 41:669-685 PubMed32424773

2020

Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms.

Applications

Unspecified application

Species

Unspecified reactive species

Channa Bao,Bekim Bajrami,Douglas J Marcotte,Jayanth V Chodaparambil,Hannah M Kerns,Jaclyn Henderson,Ru Wei,Benbo Gao,Gregory M Dillon

PloS one 15:e0228771 PubMed32255788

2020

Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites.

Applications

Unspecified application

Species

Unspecified reactive species

Gregory M Dillon,Jaclyn L Henderson,Channa Bao,John A Joyce,Michael Calhoun,Brenda Amaral,Kristopher W King,Bekim Bajrami,Dania Rabah

Acta neuropathologica communications 7:192 PubMed31796124

2019

A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.

Applications

Unspecified application

Species

Unspecified reactive species

Ebru Ercan-Herbst,Jens Ehrig,David C Schöndorf,Annika Behrendt,Bernd Klaus,Borja Gomez Ramos,Nuria Prat Oriol,Christian Weber,Dagmar E Ehrnhoefer

Frontiers in cellular neuroscience 13:298 PubMed31338023

2019

Astrocytic Insulin-Like Growth Factor-1 Protects Neurons Against Excitotoxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Chen,Bin He,Wusong Tong,Jinsong Zeng,Ping Zheng

Experimental brain research 236:2857-2866 PubMed30056470

2018

Dihydrolipoamide dehydrogenase suppression induces human tau phosphorylation by increasing whole body glucose levels in a C. elegans model of Alzheimer's Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Waqar Ahmad

Molecular neurodegeneration 12:87 PubMed29157277

2017

A validated antibody panel for the characterization of tau post-translational modifications.

Applications

PepArr, ICC/IF, WB

Species

Unspecified reactive species, Unspecified reactive species, Unspecified reactive species

Ebru Ercan,Sameh Eid,Christian Weber,Alexandra Kowalski,Maria Bichmann,Annika Behrendt,Frank Matthes,Sybille Krauss,Peter Reinhardt,Simone Fulle,Dagmar E Ehrnhoefer

Biology open 6:1013-1023 PubMed28711868

2017

Human TTBK1, TTBK2 and MARK1 kinase toxicity in is exacerbated by co-expression of human Tau.

Applications

WB

Species

Unspecified reactive species

Josefin Fernius,Annika Starkenberg,Malgorzata Pokrzywa,Stefan Thor
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com